David B. Turner

ORCID: 0000-0001-6130-5914 · 1 paper in corpus
other 2019
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V ·doi:10.1016/j.ejpb.2019.05.024

Oral bioavailability of poorly water soluble (BCS II) drugs like danazol can be minimal without the necessary formulation strategies. Availability of in vitro physicochemical and in vivo pharmacokinetic studies can be valuable when designin…